Cerebral Venous Thrombosis
📧 Sign up to get email alerts when something new happens for Cerebral Venous Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Thrombus Composition in Cerebral Infarctions: Study of Its Association With Plasma Biomarkers, Treatment Efficacy, Etiology and Prognosis.
This clinical trial investigates thrombus composition in cerebral infarctions and its association with plasma biomarkers, treatment efficacy…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis [Phase 4]
Clinical trial update for a Phase 4 randomized study comparing anticoagulation with or without batroxobin in acute cerebral venous thrombosi…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam
An update on an ongoing Vietnam trial evaluating outcomes of direct oral anticoagulants for cerebral venous thrombosis. No results are repor…
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: The Norwegian Cerebral Venous Thrombosis Study
This clinical trial update indicates that the Norwegian Cerebral Venous Thrombosis Study is currently recruiting to study cerebral venous th…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis [Phase 3]
Phase 3 clinical trial comparing rivaroxaban versus apixaban for cerebral venous thrombosis, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis
Ongoing clinical trial is recruiting to evaluate direct oral anticoagulants for the treatment of cerebral venous thrombosis.
-
CLINICAL_TRIALS research · 2017-11-22Clinical Trial Update: The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of dabigatran etexilate for the treatment of cerebral venous thrombosis, sponsored by Capit…